| Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy M Colaneri, N Amarasinghe, L Rezzonico, TC Pieri, E Segalini, M Sambo, ... International Journal of Infectious Diseases 121, 157-160, 2022 | 17 | 2022 |
| COVID-19 infection among incarcerated individuals and prison staff in lombardy, Italy, March 2020 to February 2021 S Mazzilli, L Tavoschi, A Soria, M Fornili, G Cocca, T Sebastiani, ... JAMA network open 5 (3), e224862-e224862, 2022 | 11 | 2022 |
| Impact of treatment with direct‐acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co‐infected individuals R Rossotti, M Merli, C Baiguera, NB Bana, LF Rezzonico, F D'Amico, ... Journal of Viral Hepatitis 30 (6), 530-539, 2023 | 3 | 2023 |
| Meropenem–vaborbactam for the treatment of post-neurosurgical meningitis caused by KPC producer Klebsiella pneumoniae: A case report and review of the literature LF Rezzonico, F Peracchi, M Vecchi, G Bassi, M Merli, NB Bana, G Travi, ... Antibiotics 13 (4), 331, 2024 | 1 | 2024 |
| Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir‐based dual combinations R Rossotti, F D'Amico, NB Bana, A Nava, LF Rezzonico, A Raimondi, ... HIV medicine, 2024 | | 2024 |
| Durability and schedule compliance to cabotegravir/rilpivirine long acting: A retrospective analysis NB Bana, LF Rezzonico, F Peracchi, A Raimondi, C Moioli, L Chianura, ... HIV MEDICINE 24, 130-131, 2023 | | 2023 |
| Safety of cabotegravir/rilpivirine long acting for individuals previously exposed to HBV infection NB Bana, LF Rezzonico, F Peracchi, A Raimondi, C Moioli, L Chianura, ... HIV MEDICINE 24, 131-133, 2023 | | 2023 |
| Use of long-acting cabotegravir+ rilpivirine during hemodialysis and solid organ transplantation LF Rezzonico, L Baldassari, F Peracchi, M Merli, M Puoti, R Rossotti AIDS 37 (9), 1491-1493, 2023 | | 2023 |
